Related Experiment Videos
Infectious mononucleosis in the case of two elderly (80 and 57 years old age) patients
Aktuelle Gerontologie
|March 1, 1978
Abstract:
There are reported two cases of infectious mononucleosis in elderly. In the first case (80 years; probably the oldest in the geriatric literature) the infection provoked a very serious illness and the patient deceased three months after dimission, because of diminished resistance. In the second case the mononucleosis induced an autoimmune haemolytic anemia. The patient's daughter and granddaughter must be treated for complications of an infectious mononucleosis too.
Insights
Infectious mononucleosis is rare in the elderly, but can cause severe illness and death. This study reports two cases, one fatal, highlighting risks in geriatric populations.
Area of Science:
- Geriatric Medicine
- Infectious Diseases
- Hematology
Background:
- Infectious mononucleosis, typically caused by Epstein-Barr virus, is uncommon in elderly individuals.
- Limited data exists on the clinical presentation and outcomes of infectious mononucleosis in geriatric patients.
Observation:
- Two cases of infectious mononucleosis in elderly patients are presented.
- The first case involved an 80-year-old patient, likely the oldest reported, who experienced a severe illness and succumbed to diminished resistance three months post-discharge.
- The second case resulted in the development of autoimmune hemolytic anemia.
Findings:
- Infectious mononucleosis can lead to severe, life-threatening complications in the elderly.
- The condition can trigger autoimmune responses, such as autoimmune hemolytic anemia.
- Family members can also be affected by infectious mononucleosis complications.
Implications:
- Clinicians should consider infectious mononucleosis in the differential diagnosis of elderly patients presenting with severe illness or hematological abnormalities.
- Prompt diagnosis and management are crucial for improving outcomes in geriatric cases.
- Further research is warranted to understand the specific vulnerabilities and optimal treatment strategies for infectious mononucleosis in the elderly.